GSK plc (GSK) Stock Price, News, Quote & History - Yahoo Finance
Oops, something went wrong
Skip to navigation
Skip to main content
Skip to right column
News
Today's news
US
Politics
World
Tech
Audio
Computing
Gaming
Gaming deals Nintendo PC PlayStation Wordle Xbox
Home entertainment
TVs
Phones
Science
Streaming
Streaming reviews
Tech News
VPN
Deals
More
AI Apps AR and VR Business Cameras Cyber security Entertainment General Reviews and guides Smart home Social media Transportation Wearables
Weather
Climate change
Health
Wellness
Mental health Sexual health Dermatology Oral health Hair loss Foot health
Nutrition
Healthy eating Meal delivery Weight loss Vitamins and supplements
Fitness
Equipment Exercise
Women’s health
Sleep
Healthy aging
Hearing Mobility
Science
Originals
The 360
Newsletters
Games
Life
Health
Wellness
Nutrition Fitness Healthy aging Mental health Sleep
Your body
Dermatology Children's health Foot health Hair loss Hearing Oral health Sexual health Women’s health
Conditions
Cardiovascular health Digestive health Endocrine system
Parenting
Family health
So mini ways
Style and beauty
It Figures
Unapologetically
Horoscopes
Shopping
Style
Accessories Clothing Luggage Shoes
Beauty
Hair Makeup Skincare Sunscreen
Health
Dental Fitness Hair loss Hearing aids Mental health Mobility Nutrition Personal care Sleep Women's health
Home and garden
Bedding Cleaning Gardening Kitchen Outdoor
Pets
Tech
Accessories Audio Auto Computers Phones Smart home TVs
Gift ideas
Stores
Amazon Best Buy Home Depot Macy's Nordstrom Target Walmart Wayfair
Shopping Guides
Best non-toxic cutting boards Best heated socks Best body wash Best cordless stick vacuums Best makeup removers
Deals
Back to school
Food
Travel
Autos
Gift ideas
Buying guides
Entertainment
Celebrity
TV
Movies
Music
How to Watch
Interviews
Videos
Finance
My Portfolio
News
Latest
Stock Market
Originals
Crypto
Tariff Updates
Newsletters
Economies
Premium News
Earnings
Tech
Housing
Markets
Stocks: Most Actives
Stocks: Gainers
Stocks: Losers
Trending Tickers
Futures
World Indices
US Treasury Bonds Rates
Currencies
Crypto
Top ETFs
Top Mutual Funds
Options: Highest Open Interest
Options: Highest Implied Volatility
Sectors
Basic Materials
Communication Services
Consumer Cyclical
Consumer Defensive
Energy
Financial Services
Healthcare
Industrials
Real Estate
Technology
Utilities
Private Companies
Research
Screeners
Earnings Calendar
Economic Calendar
Stock Comparison
Advanced Chart
Currency Converter
Stock Picks
Investment Ideas
Research Reports
Personal Finance
Credit Cards
Banking
Student Loans
Personal Loans
Insurance
Mortgages
Mortgage Calculator
Taxes
Videos
Latest
Trending Stocks
Market Sunrise
Morning Brief
Opening Bid
All Shows
Stocks in Translation
Trader Talk
Financial Freestyle
ETF Report
FA Corner
Options Playbook
Watch Now
Sports
Fantasy
News
Fantasy football
Best ball
Pro Pick 'Em
College Pick 'Em
Fantasy baseball
Fantasy hockey
Fantasy basketball
Download the app
Daily fantasy
NFL
News
Scores and schedules
Standings
Stats
Teams
Players
Drafts
Injuries
Odds
Super Bowl
GameChannel
Videos
NBA
News
Draft
Scores and schedules
Standings
Stats
Teams
Players
Injuries
Videos
Odds
Playoffs
MLB
News
Scores and schedules
Standings
Stats
Teams
Players
Odds
Videos
World Baseball Classic
NHL
News
Scores and schedules
Standings
Stats
Teams
Players
Odds
Playoffs
College football
News
Scores and schedules
Standings
Rankings
Stats
Teams
College basketball
Soccer
News
Scores and schedules
Premier League
MLS
NWSL
Liga MX
CONCACAF League
Champions League
La Liga
Serie A
Bundesliga
Ligue 1
World Cup
NFL Draft
Yahoo Sports AM
Show all
WNBA
Sportsbook
NCAAF
Tennis
Golf
NASCAR
NCAAB
NCAAW
Boxing
USFL
Cycling
Motorsports
Olympics
Horse racing
GameChannel
Rivals
Newsletters
Podcasts
Videos
RSS
Jobs
Help
World Cup
More news
New on Yahoo
Creators
Tech
Local services
Moving
Roofing
Painting
Plumbing
Terms
Privacy
Privacy Dashboard
Feedback
© 2025
All rights reserved.
About our ads
Advertising
Careers
Yahoo Finance
Yahoo Finance
Search query
Select edition
USEnglish
US y LATAMEspañol
AustraliaEnglish
CanadaEnglish
CanadaFrançais
DeutschlandDeutsch
FranceFrançais
香港繁中
MalaysiaEnglish
New ZealandEnglish
SingaporeEnglish
台灣繁中
UKEnglish
News
Finance
Sports
More News Today's news
US
Politics
World
Weather
Climate change
Health
Science
Originals
Newsletters
Games
Life Health
Parenting
Style and beauty
Horoscopes
Shopping
Food
Travel
Autos
Gift ideas
Buying guides
Entertainment Celebrity
TV
Movies
Music
How to Watch
Interviews
Videos
Finance My portfolio
Watchlists
Markets
News
Videos
Screeners
Personal finance
Crypto
Sectors
Sports Fantasy
NFL
NBA
MLB
NHL
College football
College basketball
Soccer
NFL Draft
Yahoo Sports AM
New on Yahoo Creators Tech Local services
Selected edition
USEnglish
Mail
Sign in
My Portfolio
News
Latest Stock Market Originals Crypto Tariff Updates Newsletters Economies Premium News
Earnings Tech Housing
Markets
Stocks: Most Actives Stocks: Gainers Stocks: Losers Trending Tickers Futures World Indices US Treasury Bonds Rates Currencies Crypto Top ETFs Top Mutual Funds Options: Highest Open Interest Options: Highest Implied Volatility Sectors Basic Materials Communication Services Consumer Cyclical Consumer Defensive Energy Financial Services Healthcare Industrials Real Estate Technology Utilities Private Companies
Research
Screeners Earnings Calendar Economic Calendar Stock Comparison Advanced Chart Currency Converter Stock Picks
Investment Ideas
Research Reports
Personal Finance
Credit Cards Banking Student Loans Personal Loans Insurance Mortgages Mortgage Calculator Taxes
Videos
Latest Trending Stocks Market Sunrise Morning Brief Opening Bid All Shows Stocks in Translation Trader Talk Financial Freestyle ETF Report FA Corner Options Playbook
Watch Now
…
Upgrade to Premium
GSK GSK plc
40.30
-0.15%
Summary
News
Research
Chart
Community
Statistics
Historical Data
Profile
Financials
Analysis
Options
Holders
Sustainability
We are experiencing some temporary issues. The market data on this page is currently delayed.
NYSE - Delayed Quote • USD
GSK plc (GSK)
Follow
Add holdings
Get top stock picks
40.30
-0.06
(-0.15%)
At close: September 18 at 4:00:02 PM EDT
40.18
-0.12
(-0.30%)
After hours: September 18 at 7:57:08 PM EDT
Get top stock picks
Chart Range Bar
1D
5D
-2.84%
1M
3.15%
6M
-0.22%
YTD
19.16%
1Y
-5.02%
5Y
2.65%
All
6,348.00%
Key Events
Mountain
Advanced Chart
Loading chart for GSK
Chart does not reflect overnight price.
Previous Close 40.36
Open 40.10
Bid 40.01 x 700
Ask 40.43 x 600
Day's Range 40.04 - 40.36
52 Week Range 31.72 - 42.63
Volume 2,019,480
Avg. Volume 4,688,311
Market Cap (intraday) 81.115B
Beta (5Y Monthly) 0.29
PE Ratio (TTM) 17.83
EPS (TTM) 2.26
Earnings Date Oct 29, 2025
Forward Dividend & Yield 1.65 (4.08%)
Ex-Dividend Date Aug 15, 2025
1y Target Est 41.40
GSK plc Overview Drug Manufacturers - General / Healthcare
GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through Commercial Operations and Total R&D segments. The company offers specialty medicines that include oncology, respiratory/immunology, inflammation, and inhaled medicines for HIV, respiratory eosinophildriven diseases, lupus and lupus nephritis, ovarian cancer, and endometrial cancer. It also provides vaccines for Shingles, Meningitis, RSV, Seasonal Influenza, Hepatitis, Diphtheria, Tetanus, Acellular Pertussis, Rotavirus, Pertussis, Polio, Haemophilus, Invasive Diseases, Pneumonia, Acute Otitis Media, Measles, Mumps, Rubella and Chickenpox, and Human Papilloma Virus. Additionally, the company offers general medicines for asthma, COPD, bacterial infection, benign prostatic hyperplasia, allergic rhinitis, and inflammatory skin conditions. It has a collaboration agreement with CureVac to develop mRNA vaccines for infectious diseases. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in London, United Kingdom. www.gsk.com
68,629 Full Time Employees December 31 Fiscal Year Ends Healthcare
Sector Drug Manufacturers - General
Industry
More about GSK plc
Recent News: GSK View More
All
News
Earnings Calls
Press Releases
SEC Filings
RHHBY to Acquire 89bio for $3.5B, Add Late-Stage MASH Drug to Pipeline
Zacks • 8h ago
GSK Commits $30 Billion To U.S. Expansion Over Five Years
GuruFocus.com • 18h ago
Apple and Citi CEOs Join Trump and King Charles at State Dinner
Bloomberg • 1d ago
Sector Update: Health Care Stocks Edge Higher Late Afternoon
PREMIUM MT Newswires • 1d ago
GSK Commits $30B to Boost U.S. Pharma Expansion
GuruFocus.com • 1d ago
GSK Just Dropped $30 Billion on America's Biotech Future--Here's What That Buys
GuruFocus.com • 1d ago
GSK to Invest $30B in U.S. R&D and Manufacturing Over 5 Years
Zacks • 1d ago
Top Midday Stories: Markets Await Fed Rate Decision; China Regulator Reportedly Bans Nvidia Chip Sales to Alibaba, ByteDance
PREMIUM MT Newswires • 1d ago
LLY's $5B Virginia Plant Plan: Will U.S. Manufacturing Shift Pay Off?
Zacks • 1d ago
Trump's UK visit: US Big Tech to invest billions in UK's AI
Yahoo Finance Video • 1d ago
Market Chatter: Pharmaceutical Firms Pledge $350 Billion US Investment Amid Tariff Threats
PREMIUM MT Newswires • 1d ago
View More
Related Videos: GSK
Trump's UK visit: US Big Tech to invest billions in UK's AI President Trump is visiting the UK to meet with Prime Minister Keir Starmer on Thursday, accompanied by several Big Tech CEOs. This comes as names like Microsoft (MSFT), Google (GOOG, GOOGL), Nvidia (NVDA), Salesforce (CRM), OpenAI (OPAI.PVT), and GSK (GSK) pledged $42.3 billion worth of artificial intelligence (AI) infrastructure investments in the UK as part of the "Tech Prosperity Deal." Yahoo Finance anchor Ramzan Karmali joins Morning Brief with Julie Hyman to discuss the details. To watch more expert insights and analysis on the latest market action, check out more Morning Brief.
Yahoo Finance Video · yesterday
NVDA
+3.49%
GLAXF
0.00%
Performance Overview: GSK
Trailing total returns as of 9/18/2025, which may include dividends or other distributions. Benchmark is FTSE 100 (^FTSE)
.
YTD Return
GSK 23.20%
FTSE 100 (^FTSE) 12.91%
1-Year Return
GSK 0.67%
FTSE 100 (^FTSE) 11.81%
3-Year Return
GSK 47.57%
FTSE 100 (^FTSE) 27.52%
5-Year Return
GSK 28.44%
FTSE 100 (^FTSE) 53.62%
Compare To: GSK Compare
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
GSK GSK plc
40.30 -0.15%
Mkt Cap
81.115B
Industry Drug Manufacturers—General
SNY Sanofi
47.68 +1.51%
Mkt Cap
116.199B
Industry Drug Manufacturers—General
BMY Bristol-Myers Squibb Company
45.60 -1.19%
Mkt Cap
92.816B
Industry Drug Manufacturers—General
AZN AstraZeneca PLC
77.07 -0.80%
Mkt Cap
238.956B
Industry Drug Manufacturers—General
RHHBY Roche Holding AG
41.14 -0.12%
Mkt Cap
265.44B
Industry Drug Manufacturers—General
NVS Novartis AG
122.29 -0.15%
Mkt Cap
237.516B
Industry Drug Manufacturers—General
MRK Merck & Co., Inc.
81.53 +0.48%
Mkt Cap
203.644B
Industry Drug Manufacturers—General
GILD Gilead Sciences, Inc.
113.62 +1.21%
Mkt Cap
140.98B
Industry Drug Manufacturers—General
AMGN Amgen Inc.
275.83 +0.41%
Mkt Cap
148.496B
Industry Drug Manufacturers—General
PFE Pfizer Inc.
24.15 +0.42%
Mkt Cap
137.306B
Industry Drug Manufacturers—General
JNJ Johnson & Johnson
174.16 -1.72%
Mkt Cap
419.436B
Industry Drug Manufacturers—General
Statistics: GSK View More
Valuation Measures
Current
Quarterly
Annual
As of 9/17/2025 Market Cap
80.98B
Enterprise Value
99.73B
Trailing P/E
17.87
Forward P/E
7.67
PEG Ratio (5yr expected)
0.35
Price/Sales
(ttm) 1.94
Price/Book
(mrq) 4.02
Enterprise Value/Revenue
2.31
Enterprise Value/EBITDA
8.48
Financial Highlights
Profitability and Income Statement
Profit Margin
10.82%
Return on Assets
(ttm) 6.79%
Return on Equity
(ttm) 28.33%
Revenue
(ttm) 31.63B
Net Income Avi to Common
(ttm) 3.42B
Diluted EPS
(ttm) 2.26
Balance Sheet and Cash Flow
Total Cash
(mrq) 3.62B
Total Debt/Equity
(mrq) 120.90%
Levered Free Cash Flow
(ttm) 5.48B
View More
Research Analysis: GSK View More
Earnings Per Share
Consensus EPS
Revenue vs. Earnings
Revenue 7.99B
Earnings 1.89B
Q324
Q424
Q125
Q225
0
2B
4B
6B
8B
Analyst Recommendations
Strong Buy
Buy
Hold
Underperform
Sell
Analyst Price Targets
35.50 Low 41.40 Average
40.30 Current
58.00 High
View More
Research Reports: GSK
View More
Morningstar | A Weekly Summary of Stock Ideas and Developments in the Companies We Cover
In this edition, US pricing and tariff risks manageable for biopharma; a look at Klarna's IPO; examining how spinoffs reshape corporate value; and we launch coverage of Penumbra; and
Adobe, Edenred, and Alibaba Group.
Morningstar• 6 days ago
Company advances pipeline; recent weakness offers buying opportunity
GSK plc, based in Brentford, UK, is a global healthcare company engaged in the discovery, development, manufacture and marketing of pharmaceutical products. The company's leading products include treatments for asthma and COPD; products for HIV infection; and a range of vaccines. The company has active research and development programs in immuno-inflammation, neuroscience, metabolic pathways, ophthalmology, respiratory and infectious diseases, and biopharmaceuticals.
Rating
Price Target
Argus• 20 days ago
Stock indices are lower at midday on Friday. The consumer sentiment survey
Stock indices are lower at midday on Friday. The consumer sentiment survey from the University of Michigan showed that expectations from consumers about inflation increasing one year from now are on the rise. Meanwhile, the PCE report that came out this morning indicated that price increases held steady month over month, while the core PCE report indicated that prices rose at the fastest pace since early 2025.
Argus• 20 days ago
GSK Earnings: Strong Start to the Year Driven by Growth in Specialty Medicines
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Rating
Price Target
Morningstar• last month
View More
People Also Watch
SNY
Sanofi
47.68 +1.51%
AZN
AstraZeneca PLC
77.07 -0.80%
NVS
Novartis AG
122.29 -0.15%
BMY
Bristol-Myers Squibb Company
45.60 -1.19%
LLY
Eli Lilly and Company
762.93 +0.37%
Copyright © 2025 Yahoo. All rights reserved.
What's trending Dow Jones
S&P 500
DAX Index
Nvidia
Tesla
DJT
Tariffs
Explore more Mortgages
Credit Cards
Sectors
Crypto Heatmap
Financial News
About Data Disclaimer
Help
Feedback
Sitemap
Licensing
What's New
About Our Ads
Premium Plans
Terms
and Privacy Policy
Privacy Dashboard
More Info
U.S. markets closed
US
Europe
Asia
Cryptocurrencies
Rates
Commodities
Currencies
S&P Futures
6,701.00 +7.50 (+0.11%)
Dow Futures
46,576.00 +60.00 (+0.13%)
Nasdaq Futures
24,724.25 +18.75 (+0.08%)
Russell 2000 Futures
2,496.40 +8.90 (+0.36%)
VIX
15.70 -0.02 (-0.13%)
Gold
3,671.60 -6.70 (-0.18%)
Portfolio
Portfolio
Sign in to access your portfolio Sign in
Top gainers
ETNB 89bio, Inc. 14.96 +6.88 (+85.15%)
TIC Acuren Corporation 13.45 +2.51 (+22.94%)
INTC Intel Corporation 30.57 +5.67 (+22.77%)
BLSH Bullish 65.61 +11.26 (+20.72%)
QS QuantumScape Corporation 12.13 +1.87 (+18.23%)
Top losers
QMMM QMMM Holdings Limited 89.02 -16.62 (-15.73%)
YPF YPF Sociedad Anónima 24.41 -2.83 (-10.39%)
FDS FactSet Research Systems Inc. 301.23 -34.81 (-10.36%)
TEO Telecom Argentina S.A. 6.52 -0.66 (-9.19%)
SGHC Super Group (SGHC) Limited 11.69 -1.14 (-8.89%)
Most active
INTC Intel Corporation 30.57 +5.67 (+22.77%)
OPEN Opendoor Technologies Inc. 9.94 -0.27 (-2.64%)
SNAP Snap Inc. 8.44 +0.45 (+5.63%)
NVDA NVIDIA Corporation 176.24 +5.95 (+3.49%)
PLUG Plug Power Inc. 2.1000 +0.0900 (+4.48%)
Earnings events
My earnings events
Earnings events
Trending tickers
INTC Intel Corporation 30.57 +5.67 (+22.77%)
QS QuantumScape Corporation 12.13 +1.87 (+18.23%)
FDX FedEx Corporation 226.50 +0.72 (+0.32%)
OKLO Oklo Inc. 104.97 +9.68 (+10.16%)
LEN Lennar Corporation 132.87 -0.10 (-0.08%)
Top economic events
Top economic events
United States
Fed Funds Tgt Rate
Sep 17, 2025, 2:00 PM EDT Prior: P: 4.38 New: N: 4.25
Fed Funds Tgt Rate
Sep 17, 2025, 2:00 PM EDT Prior: Prior: 4.38 New: New: 4.25
Edit your Dock
Terms
and Privacy Policy
Privacy Dashboard
Ad Terms
Feedback
More Info